InterVenn Biosciences
Carolyn Bertozzi is on the Board of Advisors at InterVenn Biosciences.
This person is not in the org chart
This person is not in any offices
InterVenn Biosciences
1 followers
InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together with applications from the Vista suite of solutions for treatment and monitoring, immune profiling, patient stratification, and disease progression.